Shares of KIMS (Krishna Institute of Medical Sciences) jumped nearly 2% after HSBC raised ts target price to ₹670.
HSBC remains bullish on India’s hospital sector, forecasting strong growth with substantial bed additions in 2025. Seven covered hospitals, including KIMS, are expected to drive around 40% of the planned capacity expansion. While revenue growth is projected to stay robust, EBITDA margins may face some pressure due to rising capital expenditures. Investors are optimistic as KIMS continues to position itself for growth in the expanding healthcare market.
KIMS shares opened at ₹579.20, reaching a high of ₹583.40 and a low of ₹570.25. The stock is currently trading below its 52-week high of ₹615.00, with a low of ₹350.00. With HSBC’s recent target price upgrade to ₹670, investor sentiment remains positive
As of 12:06 pm, KIMS shares were trading 1.35% higher at Rs 581.85 on the NSE.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
